37 related articles for article (PubMed ID: 2104770)
1. LC-MS-based plasma metabolomics reveals metabolic variations in ovariectomy-induced osteoporosis in female Wistar rats.
Hu Y; Zhang X; Shan Y
RSC Adv; 2018 Jul; 8(44):24932-24941. PubMed ID: 35542168
[TBL] [Abstract][Full Text] [Related]
2. Effect of tocotrienol from
Mohamad NV; Ima-Nirwana S; Chin KY
Drug Des Devel Ther; 2018; 12():555-564. PubMed ID: 29588572
[TBL] [Abstract][Full Text] [Related]
3. Establishing an Animal Model of Secondary Osteoporosis by Using a Gonadotropin-releasing Hormone Agonist.
Mohamad NV; Che Zulkepli MAA; May Theseira K; Zulkifli N; Shahrom NQ; Ridzuan NAM; Jamil NA; Soelaiman IN; Chin KY
Int J Med Sci; 2018; 15(4):300-308. PubMed ID: 29511366
[No Abstract] [Full Text] [Related]
4. Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution.
Danielsen CC; Mosekilde L; Svenstrup B
Calcif Tissue Int; 1993 Jan; 52(1):26-33. PubMed ID: 8453502
[TBL] [Abstract][Full Text] [Related]
5. Toward a cure for osteoporosis: reversal of excessive bone fragility.
Turner CH
Osteoporos Int; 1991 Oct; 2(1):12-9. PubMed ID: 1790415
[TBL] [Abstract][Full Text] [Related]
6. Buserelin-mediated osteoporosis: effects of restoring estrogen on bone resorption and whole body calcium content in the rat.
Goulding A; Gold E
Calcif Tissue Int; 1990 Jan; 46(1):14-9. PubMed ID: 2104770
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin.
Goulding A; Gold E; Feng W
Bone Miner; 1992 Aug; 18(2):143-52. PubMed ID: 1525595
[TBL] [Abstract][Full Text] [Related]
8. 17 beta-estradiol protects rats from osteopenia associated with administration of the luteinising hormone releasing hormone (LHRH) agonist, buserelin.
Goulding A; Fisher L
Bone Miner; 1991 Apr; 13(1):47-53. PubMed ID: 1905969
[TBL] [Abstract][Full Text] [Related]
9. Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat.
Goulding A; Fisher L
J Bone Miner Res; 1991 Nov; 6(11):1177-81. PubMed ID: 1805541
[TBL] [Abstract][Full Text] [Related]
10. A new way to induce oestrogen-deficiency osteopaenia in the rat: comparison of the effects of surgical ovariectomy and administration of the LHRH agonist buserelin on bone resorption and composition.
Goulding A; Gold E
J Endocrinol; 1989 May; 121(2):293-8. PubMed ID: 2502594
[TBL] [Abstract][Full Text] [Related]
11. Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
Goulding A; Gold E
J Endocrinol; 1993 Apr; 137(1):27-33. PubMed ID: 8492074
[TBL] [Abstract][Full Text] [Related]
12. "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.
Meldrum DR; Chang RJ; Lu J; Vale W; Rivier J; Judd HL
J Clin Endocrinol Metab; 1982 May; 54(5):1081-3. PubMed ID: 6801075
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
